Showing results (1451-1460 of 2,774) with videos related to
Sort By:
Pageof 278
Bioanalysis|November 23, 2022
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matricesZhiyin Xun, Phillip Wang, Ryan McGeeBioanalysis|October 2, 2020
Accelerating protein biomarker discovery and translation from proteomics research for clinical utilityJiwen Chen, Naiyu ZhengBioanalysis|March 27, 2020
A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluidLilly Schwieler, Ada Trepci, Stanislaw Krzyzanowski, et al.Bioanalysis|March 27, 2020
Selection of a surrogate matrix for the quantification of an endogenous analyte in dried whole bloodAmy E Leaney, Carl Horner, Philip B Grace, et al.Bioanalysis|January 28, 2020
A new approach for characterization of phosphatidylcholines and lysophosphatidylcholine in human plasmaAlaa Khedr, Maan T Khayat, Ahdab N KhayyatBioanalysis|October 29, 2020
US FDA-validated green GC-MS method for analysis of gabapentin, tramadol and/or amitriptyline mixtures in biological fluidsIbrahim A Naguib, Nesma A Ali, Fadwa A Elroby, et al.Bioanalysis|June 23, 2022
LC-MS/MS assay of fluoropezil and its two major metabolites in human plasma: an application to pharmacokinetic studiesRuncong Guo, Jiafeng Hu, Jiao Jing, et al.Bioanalysis|January 11, 2021
Key points of technical review for the registration of SARS-CoV-2 antigen/antibody testsHongran Li, Jingyun He, Wen Bao, et al.Bioanalysis|June 3, 2021
An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug developmentWenkui Li, Jim Glick, Panos Hatsis, et al.Bioanalysis|June 20, 2017
Performance evaluation of three platforms with ultrasensitive ligand-binding assay potentialKyra Juliana Cowan, Albert Geiger, Hans Hornauer, et al.Pageof 278